Values-Affirmation + Education Intervention Targeting Medication Adherence in Older Adults With Heart Failure
Pilot Randomized Controlled Trial of a Values-Affirmation Intervention Targeting Medication Adherence in Older Adults With Heart Failure
1 other identifier
interventional
43
1 country
1
Brief Summary
The goals of this study are to determine the (1) feasibility and (2) acceptability of the study procedures through a pilot randomized controlled trial of a values affirmation intervention targeting medication adherence in adults with heart failure enrolled in cardiac rehabilitation relative to usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2022
CompletedFirst Submitted
Initial submission to the registry
October 3, 2022
CompletedFirst Posted
Study publicly available on registry
October 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2025
CompletedResults Posted
Study results publicly available
November 24, 2025
CompletedNovember 24, 2025
January 1, 2025
2.3 years
October 3, 2022
August 14, 2025
November 10, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Acceptability of Intervention and Study Procedures
Participant self-reported satisfaction with intervention content and delivery \[intervention group only\] and study procedures
Post-test (2-months)
Retention
Proportion of enrolled participants who completed the final assessment
2 months
Secondary Outcomes (3)
Medication Adherence (Electronically Monitored)
1 month; calculated as the difference between Baseline and post-test
Change in Medication Adherence (Self-report)
Baseline, post-test (2-months)
Medication Adherence (Pill Count)
Baseline, post-test (2-months)
Other Outcomes (5)
Positive and Negative Affect
Baseline, post-test (2-months)
Perceived Stress-4
Baseline, post-test (2-months)
Medication Self-Efficacy
Baseline, post-test (2-months)
- +2 more other outcomes
Study Arms (2)
Values Affirmation + Usual Care
EXPERIMENTALUsual Care
OTHERInterventions
Participants will engage in a brief values-affirmation exercise to target personal motivation and openness to medication adherence. The interventionist will then review tailored medication education and individual skills training recommendations. The participant's study medication monitoring devices will be labeled with the participants' most important core value(s). Participants will also continue with their usual care.
Participants will be asked to continue with their usual care (e.g., cardiac rehabilitation, ongoing medical management)
Eligibility Criteria
You may qualify if:
- Heart failure
- Enrolled in cardiac rehabilitation
- Read and understand English
You may not qualify if:
- Current participation in another medication-monitoring clinical or research protocol
- New York Heart Association class IV heart failure
- Diagnosis of Alzheimer's, dementia, or severe cognitive impairment indicated on screening
- Current suicidality or psychosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Miriam Hospitallead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
The Miriam Hospital
Providence, Rhode Island, 02906, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Emily Gathright
- Organization
- The Miriam Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2022
First Posted
October 12, 2022
Study Start
September 15, 2022
Primary Completion
January 15, 2025
Study Completion
January 15, 2025
Last Updated
November 24, 2025
Results First Posted
November 24, 2025
Record last verified: 2025-01